NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis → Invest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a Century (From Starpax) (Ad) Free AVNS Stock Alerts $20.02 +0.14 (+0.70%) (As of 01:05 PM ET) Add Compare Share Share Today's Range$19.95▼$20.1950-Day Range$17.85▼$19.9452-Week Range$17.24▼$26.56Volume31,477 shsAverage Volume269,306 shsMarket Capitalization$918.92 millionP/E RatioN/ADividend YieldN/APrice Target$31.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Avanos Medical alerts: Email Address Avanos Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside54.5% Upside$31.00 Price TargetShort InterestHealthy2.16% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.44Based on 6 Articles This WeekInsider TradingSelling Shares$152,960 Sold Last QuarterProj. Earnings Growth31.88%From $1.38 to $1.82 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.91 out of 5 starsMedical Sector609th out of 2,771 stocksSurgical Appliances & Supplies Industry25th out of 54 stocks 3.2 Analyst's Opinion Consensus RatingAvanos Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageAvanos Medical has only been the subject of 1 research reports in the past 90 days.Read more about Avanos Medical's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.16% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Avanos Medical has recently decreased by 17.24%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVNS. Previous Next 2.5 News and Social Media Coverage News SentimentAvanos Medical has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Avanos Medical this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have sold 1,441.16% more of their company's stock than they have bought. Specifically, they have bought $9,925.00 in company stock and sold $152,960.00 in company stock.Percentage Held by InsidersOnly 3.94% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avanos Medical's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Avanos Medical are expected to grow by 31.88% in the coming year, from $1.38 to $1.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -15.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -15.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Avanos Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingThe World’s Richest Man Blindsided by AIThese billionaires know that early investors in AI stand to make a lot of money. The same is true for everyday Americans... including you.Get the full story here. About Avanos Medical Stock (NYSE:AVNS)Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Read More AVNS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVNS Stock News HeadlinesMay 13 at 7:15 AM | prnewswire.comAvanos Medical, Inc. Appoints Sig Delgado as Senior Vice President, Integrated Supply ChainMay 11 at 3:10 AM | americanbankingnews.comAvanos Medical (NYSE:AVNS) Stock Rating Upgraded by StockNews.comMay 8, 2024 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Given "Market Perform" Rating at JMP SecuritiesMay 6, 2024 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call TranscriptMay 6, 2024 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Downgraded by StockNews.comMay 3, 2024 | finance.yahoo.comAvanos Medical First Quarter 2024 Earnings: EPS: US$0.011 (vs US$0.17 loss in 1Q 2023)May 3, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 2, 2024 | msn.comAVNS Stock Earnings: Avanos Medical Misses EPS, Beats Revenue for Q1 2024May 2, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses Revenue EstimatesMay 2, 2024 | sfgate.comAvanos Medical: Q1 Earnings SnapshotMay 2, 2024 | prnewswire.comAvanos Medical, Inc. Announces First Quarter 2024 ResultsMay 1, 2024 | msn.comAvanos Medical Q1 2024 Earnings PreviewApril 25, 2024 | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial ResultsApril 19, 2024 | finance.yahoo.comHere's Why Shareholders May Want To Be Cautious With Increasing Avanos Medical, Inc.'s (NYSE:AVNS) CEO Pay PacketFebruary 22, 2024 | finance.yahoo.comAvanos Medical Full Year 2023 Earnings: US$0.21 loss per share (vs US$1.08 profit in FY 2022)February 22, 2024 | markets.businessinsider.comAvanos Medical Issues Voluntary Recall Amid Nurse Assist Sterile Water Product RecallFebruary 21, 2024 | finance.yahoo.comAvanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products RecallFebruary 21, 2024 | prnewswire.comAvanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products RecallFebruary 21, 2024 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Call TranscriptFebruary 20, 2024 | msn.comSupplementary Review: Avanos Medical (AVNS), February 20, 2024February 20, 2024 | seekingalpha.comAvanos Medical, Inc. 2023 Q4 - Results - Earnings Call PresentationFebruary 20, 2024 | msn.comAvanos Medical reports mixed Q4 results; initiates FY24 outlookFebruary 20, 2024 | finance.yahoo.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 ResultsFebruary 20, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Reports Mixed 2023 Financial Results Amid Transformation InitiativeFebruary 20, 2024 | prnewswire.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 ResultsSee More Headlines Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today5/14/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:AVNS CUSIPN/A CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees3,771Year FoundedN/APrice Target and Rating Average Stock Price Target$31.00 High Stock Price Target$31.00 Low Stock Price Target$31.00 Potential Upside/Downside+55.9%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.33) Trailing P/E RatioN/A Forward P/E Ratio14.41 P/E GrowthN/ANet Income$-61,800,000.00 Net Margins-9.15% Pretax Margin0.40% Return on Equity4.10% Return on Assets2.99% Debt Debt-to-Equity Ratio0.14 Current Ratio2.28 Quick Ratio1.47 Sales & Book Value Annual Sales$673.30 million Price / Sales1.36 Cash Flow$2.05 per share Price / Cash Flow9.68 Book Value$26.63 per share Price / Book0.75Miscellaneous Outstanding Shares45,900,000Free Float44,095,000Market Cap$912.49 million OptionableOptionable Beta0.97 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Joseph F. Woody (Age 58)CEO & Director Comp: $2.21MMr. Michael C. Greiner (Age 51)Senior VP, CFO & Chief Transformation Officer Comp: $986.42kMs. Mojirade James (Age 57)Senior VP, General Counsel & Corporate Secretary Comp: $728.66kMr. Kerr W. Holbrook (Age 57)Senior VP & Chief Commercial Officer Comp: $747.61kMr. Sudhakar Varshney (Age 47)Senior Vice President of Global Supply Chain & Procurement Comp: $1.02MMr. John Joseph HurleyPrincipal Accounting Officer & ControllerMr. David CrawfordVP of FP&A and Investor Relations and TreasurerMs. Michelle ScharfenbergSenior VP and Chief Ethics & Compliance OfficerMr. Scott GalovanVice President of Strategy & Corporate DevelopmentJohn W. CatoVice President of Human ResourcesMore ExecutivesKey CompetitorsJin Medical InternationalNASDAQ:ZJYLEstablishment LabsNASDAQ:ESTASanara MedTechNASDAQ:SMTIEnovisNYSE:ENOVPraxis Precision MedicinesNASDAQ:PRAXView All CompetitorsInsiders & InstitutionsPitcairn Co.Bought 1,606 shares on 5/14/2024Ownership: 0.035%Vanguard Group Inc.Sold 18,774 shares on 5/10/2024Ownership: 11.762%Jupiter Asset Management Ltd.Sold 97,431 shares on 5/10/2024Ownership: 0.116%Foundry Partners LLCSold 207,774 shares on 5/9/2024Ownership: 0.356%State Board of Administration of Florida Retirement SystemBought 1,516 shares on 5/9/2024Ownership: 0.042%View All Insider TransactionsView All Institutional Transactions AVNS Stock Analysis - Frequently Asked Questions Should I buy or sell Avanos Medical stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AVNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares. View AVNS analyst ratings or view top-rated stocks. What is Avanos Medical's stock price target for 2024? 3 Wall Street analysts have issued twelve-month price objectives for Avanos Medical's shares. Their AVNS share price targets range from $31.00 to $31.00. On average, they predict the company's stock price to reach $31.00 in the next year. This suggests a possible upside of 54.5% from the stock's current price. View analysts price targets for AVNS or view top-rated stocks among Wall Street analysts. How have AVNS shares performed in 2024? Avanos Medical's stock was trading at $22.43 at the beginning of 2024. Since then, AVNS shares have decreased by 10.5% and is now trading at $20.07. View the best growth stocks for 2024 here. Are investors shorting Avanos Medical? Avanos Medical saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 968,300 shares, a decline of 17.2% from the April 15th total of 1,170,000 shares. Based on an average daily volume of 240,100 shares, the days-to-cover ratio is presently 4.0 days. Currently, 2.2% of the company's stock are sold short. View Avanos Medical's Short Interest. When is Avanos Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our AVNS earnings forecast. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) released its quarterly earnings data on Thursday, May, 2nd. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.21 by $0.02. The business earned $166.10 million during the quarter, compared to the consensus estimate of $162.90 million. Avanos Medical had a positive trailing twelve-month return on equity of 4.10% and a negative net margin of 9.15%. The business's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.27 EPS. What ETF holds Avanos Medical's stock? Invesco S&P SmallCap Health Care ETF holds 84,593 shares of AVNS stock, representing 0.75% of its portfolio. What guidance has Avanos Medical issued on next quarter's earnings? Avanos Medical updated its FY 2024 earnings guidance on Friday, May, 3rd. The company provided earnings per share (EPS) guidance of 1.300-1.450 for the period, compared to the consensus EPS estimate of 1.380. The company issued revenue guidance of $685.0 million-$705.0 million, compared to the consensus revenue estimate of $691.0 million. What is Joseph F. Woody's approval rating as Avanos Medical's CEO? 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), RTX (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA). Who are Avanos Medical's major shareholders? Avanos Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.76%), William Blair Investment Management LLC (3.10%), Paradice Investment Management LLC (2.78%), Tributary Capital Management LLC (1.61%), Principal Financial Group Inc. (0.56%) and Empowered Funds LLC (0.39%). Insiders that own company stock include Julie Ann Shimer, Michael Greiner and Patrick J Oleary. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AVNS) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.